Skip to content
healthcare.dev

Otulfi

NDC 65219-828, ustekinumab-aauz, solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-828
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-828 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
65219-828-05652190828051 VIAL in 1 CARTON (65219-828-05) / 26 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/853130e5-7406-4fd6-8138-ff2179195927
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65219-828

Use it

Look up 65219-828 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-828 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-828. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.